Table 2. GNAQ/GNA11 mutation status and time on study treatment in the 23 uveal melanoma patients.

Patient #	GNAQ mutation	GNA11 mutation	Months on study treatmenta
1	UNK	UNK	24.5+
2	UNK	UNK	19.9+
3	UNK	UNK	14.9+
4	UNK	UNK	14.6+
5	UNK	UNK	11.6
6	R183Q	ND	10.3
7	UNK	UNK	9.7
8	ND	Q209L	8.7
9	UNK	UNK	6.5
10	UNK	UNK	5.0
11	UNK	UNK	4.6
12	ND	UNK	4.3
13	UNK	UNK	3.5
14	ND	R183C	3.0
15	Q209P	UNK	3.0
16	Q209P	ND	2.3
17	ND	Q209L	2.1
18	Q209P	UNK	1.8
19	UNK	UNK	1.7
20	ND	Q209L	1.4
21	Q209L	ND	1.4
22	UNK	UNK	1.4
23	UNK	UNK	1.3

Abbreviations: ND=not detected; UNK=unknown.

^aMonths with a plus (+) indicate patients who remain on study treatment as of the data cutoff.